D
LSL Pharma Group Inc. LSL.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 5.22M 4.82M 3.85M 2.94M 3.06M
Total Other Revenue -- -- -- -- --
Total Revenue 5.22M 4.82M 3.85M 2.94M 3.06M
Cost of Revenue 3.73M 3.37M 2.80M 2.06M 1.94M
Gross Profit 1.49M 1.45M 1.05M 875.40K 1.12M
SG&A Expenses 1.27M 1.20M 970.10K 786.70K 1.23M
Depreciation & Amortization -- -- -72.90K 25.70K --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 5.00M 4.57M 3.69M 2.88M 3.17M
Operating Income 219.70K 256.80K 154.30K 63.10K -103.80K
Income Before Tax -281.20K -189.50K 3.25M -283.00K -377.10K
Income Tax Expenses -- -- 35.70K -- --
Earnings from Continuing Operations -281.20K -189.50K 3.21M -283.00K -377.10K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -281.20K -189.50K 3.21M -283.00K -377.10K
EBIT 219.70K 256.80K 154.30K 63.10K -103.80K
EBITDA 730.70K 667.20K 343.60K 322.60K 149.10K
EPS Basic 0.00 0.00 0.03 0.00 0.00
Normalized Basic EPS 0.00 0.00 0.00 0.00 0.00
EPS Diluted 0.00 0.00 0.03 0.00 0.00
Normalized Diluted EPS 0.00 0.00 0.00 0.00 0.00
Average Basic Shares Outstanding 115.53M 115.53M 115.93M 115.08M 105.77M
Average Diluted Shares Outstanding 115.53M 115.53M 115.93M 115.28M 105.89M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --